Connect with us

CBD

USC Trojans launch first-ever Cookies CBD partnership

Published

on


Fall is here, and America’s millions of CBD and hemp cannabinoid consumers still face an elusive expanse of rules and regulations that change as rapidly as the autumn leaves. 

  • 90 new state bills would regulate hemp
  • Cookies scores a University of Southern California deal
  • And Cann’s 2mg Grapefruit Rosemary is delicious

Looking to make sense of the chaos? Leafly has you covered. Read on for your monthly news roundup of all things CBD, delta-8, THCA, and other hemp molecules.

Top CBD, delta-8 news of September

In a dramatic first for the hemp industry, the multinational brand Cookies has entered into a multi-year sponsorship deal with a university sports team. Beginning this season, Cookies will be an official sponsor for the University of Southern California Trojans football, as well as USC’s men and women’s basketball. According to a press release, “on-site tailgate experiences” will occur at select events; your good is as good as ours what that will look like. 

In 2024 alone, US states have introduced 90 bills to regulate hemp. Yikes! The Libertarian-minded crew at the Reason Foundation recently dropped a proposal to streamline and standardize the US hemp industry. You can read it here.

California

Californians are “panic buying” thousands of dollars of CBD and other hemp products in advance of Governor Gavin Newsom (D)’s anticipated emergency ban on all hemp products containing trace amounts of THC in the Golden State. 

Related

Leafly’s 5 top THCA flower brands of 2024

Missouri

Drama continues to unfold in Missouri, where Governor Mike Parson hopes to ban intoxicating hemp products. On September 18, the state health department rebuffed Parson’s plan. Hemp sales are back on, for the time being.

Texas

The Texas Supreme Court will consider whether to outlaw delta-8 sales in an upcoming case. According to the Texas Hemp Industries Association, the state’s hemp business is worth $8.1 billion, and delta-8 makes up a $6.8 billion piece of that pie.

Related

Leafly’s top 5 delta-9 THC gummies of 2024

US Federal

A US Circuit Court ruled on September 4 that the super-potent hemp-derived cannabinoid THC-O (aka THC-O acetate) qualifies as hemp, per language in the 2018 Farm Bill. The ruling puts the Court at odds with the DEA, who argue that THC-O does not meet the definition of hemp, and thus remains federally illegal. But since SupCo struck down the Chevron Doctrine this year, circuit courts no longer need to rely on a federal agency’s opinion to issue a ruling. We’ll see what happens next.

Shop highly rated dispensaries near you

Showing you dispensaries near

See all dispensaries

On October 15, the US Supreme Court will hear oral arguments in the case of a truck driver named Douglas Horn who failed a drug test after consuming a CBD product that allegedly did not contain any THC. Horn subsequently lost his job. He hopes to sue the manufacturers of the CBD product, Dixie X.. 

On September 4, the FDA sent a warning letter to a North Carolina-based skincare company called Root Bioscience Brands. The letter alleges that the company made medical claims about its CBD and other cannabinoid products that it does not have qualification to do, since CBD is not an approved drug. The company complied.

Related

Leafly’s top 6 CBD creams of 2024

This one’s weird: Former Arkansas governor Mike Huckabee (R) is suing Meta (the parent company of Facebook). Huckabee alleges the company ran fake ads suggesting that he’s endorsing a CBD product. 

We love Cann’s 2 mg tonics!

Packaged in a cute mini-can, this zippy beverage delivers a bouquet of subtle flavors and a clean, mellow buzz…

We interrupt our news broadcast to offer a quick review on one of our favorite hemp-derived beverages Leafly HQ: Cann’s 2 THC mg Grapefruit Rosemary tonic. Packaged in a cute mini-can, this zippy beverage delivers a bouquet of subtle flavors and a clean, mellow buzz that helps it stand out among the competition. Cann’s products look classy, taste great and don’t launch you into a sugar rush (or subsequent nosedive).

Related

Leafly’s 6 top THC drinks of 2024

CBD and hemp science news

Heads up, Leafly Nation. As we reported earlier this month, a new study shows that contrary to a widely-held belief, CBD can actually enhance cannabis’ psychoactive effects, not diminish them. 

Suppository success! A survey-based study found that Foria’s CBD suppositories reduced menstrual pain and discomfort for nearly four-fifths of all participants. 

Oregon State University has received $5 million to study the potential uses of industrial hemp.

Related

Leafly’s top 6 CBD gummies of 2024

CBD and hemp industry news

Big ups, CBD! According to a new report from InsightAce Analytic, the CBD ingredient market (aka products that include CBD as an ingredient) could more than double by 2031. The report estimates that CBD saw $2.42 billion in revenue in 2023, and that the figure could reach $6.77 billion by 2031.

The first CBD lozenge has landed in Canada, thanks to a collaboration between Aurora Cannabis and Vectura Fertin Pharma. Bon appetit.

Woodstock for hemp sippers is here: The inaugural Pacific Hemp Beverage Summit is going down on October 11, 2024 in Bend, Oregon. You can find more info about the event here.

And that’s it for Leafly’s monthly novel cannabinoids news roundup. As always, it’s the Wild West out there. We’ll see you next month to report on the latest.



Source link

Cannabis

Can CBD Provide Some Foot Pain Relief

Published

on

By


It hobbles millions – but CBD could be step in the right direction for foot pain.

Roughly 75% of people suffer some type of foot pain at some point. But can CBD provide some foot pain relief? Foot pain can be debilitating, affecting daily activities and overall quality of life. Conditions like gout, plantar fasciitis, neuroma, neuropathy, and metatarsalgia are common causes of foot discomfort. While traditional treatments often come with side effects, CBD oil has emerged as a promising alternative for managing foot pain. Here’s why CBD is gaining attention for its potential benefits in alleviating foot-related issues.

RELAETD: Is GERD Helped By Cannabis

CBD, or cannabidiol, is a non-psychoactive compound found in cannabis plants. Unlike THC, CBD does not produce intoxicating effects, making it a safe option for those seeking pain relief without altering their mental state. CBD interacts with the body’s endocannabinoid system (ECS), which plays a crucial role in regulating pain, inflammation, and mood.
Photo by 2H Media via Unsplash

CBD has been shown to reduce inflammation, a key factor in many foot pain conditions. By minimizing swelling and redness, CBD can help alleviate discomfort associated with conditions like gout and plantar fasciitis.

CBD’s ability to modulate pain perception makes it effective for managing chronic pain. It can increase levels of anandamide, a compound associated with pain regulation, potentially reducing pain perception.

For conditions like neuropathy, where nerve damage leads to pain, CBD’s neuroprotective qualities can help mitigate symptoms. It may reduce neuropathic pain by interacting with receptors in the nervous system.

CBD products come in various forms, including topical creams, gels, and oils, which can be applied directly to the affected area. This localized application avoids systemic side effects and ensures targeted relief.

While more research is needed to fully understand CBD’s effects on chronic pain, existing studies suggest it is generally safe and well-tolerated. Common side effects are mild and include fatigue, decreased appetite, and dry mouth. The FDA has not approved CBD for pain management, but it is approved for certain epilepsy conditions, indicating its potential therapeutic benefits. As research continues to uncover the full potential of CBD, it may become a valuable tool in the arsenal against foot pain, providing comfort and improving quality of life for many.



Source link

Continue Reading

Cannabis

The NFL, Super Bowl, CBD And Hemp

Published

on

By


All eyes are on New Orleans for the Super Bowl. What role will CBD and Hemp play for players and fans?

The big game is in the party Capital of New Orleans this weekend – so what about the NFL, Super Bowl, CBD and hemp? New Orleans is a party capital and know for a good time. Football players and fans love a good times, but what can they do with cannabis while in the Big Easy?  For fans, while it is illegal, it isn’t hard to find and CBD and hemp products, including edibles since they are legal.

RELATED: Tips For Consuming Marijuana At Football Games

The National Football League (NFL) has historically maintained a strict stance against cannabis and its derivatives, including CBD, due to its classification as a Schedule I substance under federal law. However, recent developments have shown a shift in the league’s approach, particularly with the increasing acceptance of hemp-derived CBD.

The NFL has taken significant steps towards reevaluating its stance on cannabis, particularly CBD. The league has relaxed its cannabis policy, reducing penalties for players who test positive for cannabis. This shift focuses on ensuring responsible use without compromising health or performance2. Additionally, the NFL has partnered with researchers to study the safety and efficacy of CBD for pain management and neuroprotection from concussions, investing $1 million in such studies

CBD has emerged as an alternative for pain management and recovery in football. It is non-psychoactive, meaning it does not produce a “high,” and research suggests it can reduce inflammation, alleviate pain, and improve sleep—critical factors in athlete recovery. The NFL’s acceptance of CBD could pave the way for other sports leagues to reconsider their policies, reflecting broader societal trends toward cannabis normalization.

The NFL’s evolving stance on CBD and hemp reflects a growing recognition of the potential health benefits of these substances. As research continues and public opinion shifts, it is likely that the league will further adapt its policies. The partnership with researchers and the investment in studies signal a commitment to understanding the therapeutic benefits of CBD, particularly in managing pain and protecting against concussions.

As the NFL continues to navigate this complex issue, its decisions could have far-reaching implications for professional sports and beyond.



Source link

Continue Reading

back pain

Can Cannabis Provide Some Relief From Chronic Pain

Published

on

By


Chronic pain can be life changing – from the pain to zapped energy. But can cannabis make a difference?

An estimated 20% of adults in the US and roughly 8 million Canadians experience chronic pain. This condition is defined as pain that lasts for more than three months. It can lead to insomnia and fatigue. If can impact many other parts of life, including mood and the ability to move and body functions. It can also lead to changes in the brain and nervous system, which can make the pain worse and harder to manage. But can cannabis provide some relief from chronic pain?

RELATED: The Most Popular Marijuana Flavors

Medical cannabis (MC) and cannabidiol (CBD) have show promise in managing chronic pain, though efficacy varies by condition and formulation. Research indicates cannabinoids may reduce pain severity by 30–50% compared to placebo, particularly in neuropathic and inflammatory conditions. A 2023 systematic review of 15 studies found CBD alone or combined with tetrahydrocannabinol (THC) reduced pain by 42–66%.

Can Cannabis Provide Some Relief From Chronic Pain

Cannabinoids interact with the body’s endocannabinoid system, modulating pain signaling and inflammation:

  • THC binds to CB1 receptors in the central nervous system, altering pain perception.
  • CBD enhances anandamide (a natural pain-regulating compound) and activates glycine receptors, potentially reducing localized inflammation.
  • Combined THC:CBD formulations (e.g., nabiximols) often show superior pain relief compared to single cannabinoids, with CBD mitigating THC’s psychoactive effects.

Clinical Evidence by Condition

  • Neuropathic pain: THC:CBD sprays reduced pain scores in multiple sclerosis and spinal injury patients.
  • Arthritis/fibromyalgia: Topical CBD improved peripheral neuropathy, while oral formulations alleviated fibromyalgia pain in 30% of patients.
  • Chronic back/neck pain: Preliminary trials suggest vaporized cannabis may rival oxycodone’s efficacy.

The good news is studies report 18–29% of patients achieve ≥30% pain reduction with cannabinoids vs. 14–26% on placebo. Effective CBD doses range widely (2.5–1,500 mg/day), and prolonged use may alter drug metabolism. So trend carefully with both CBD and THC. Remember, only THC:CBD combos like nabiximols are FDA-approved for specific conditions; most CBD products remain unregulated.

RELATED: This Natural Cannabinoid Makes You Feel Happy

CBD alone shows fewer side effects (fatigue, diarrhea) than THC-containing products. Notably, real-world data associate medical cannabis with 60% reduced opioid use in chronic pain patients, though long-term safety data remain limited.

While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and further high-quality trials targeting specific pain subtypes. Current evidence supports cautious integration into multimodal pain regimens, particularly when conventional therapies fail. Always talk with your health professional when adding something new to your pain management regime.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media